glucose, (beta-d)-isomer has been researched along with Metabolically Benign Obesity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, A; Ayers, CR; Jin, E; Khan, SS; Neeland, IJ | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Metabolically Benign Obesity
Article | Year |
---|---|
Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.
Topics: Adult; Benzhydryl Compounds; Biomarkers; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Ischemia; Obesity, Metabolically Benign; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Troponin | 2021 |